Creating an entirely new treatment modality with #PrismforPTDS, I am proud and humbled to work with #client GrayMatters Health, bringing innovative solutions to mental disorder treatment.

And #breastcancer detection just got a whole lot smarter! Check out Ibex Medical Analytics's Galen Breast HER2 AI-powered biomarker scoring solution, set to improve the outcome of cancer diagnosis and patient care. #client

Have you seen Andrea Park's latest piece via FierceBiotech on Ibex Medical Analytics? It's latest $55M VC round and Galen Breast HER2 product launch are just some of the exciting things happening at Ibex. Read here: fiercebiotech.com/medtech/ibex-d…

Do you remember when you joined X? Today marks 7 years for me! Twitter/X has been a wild ride... and the platform has been my most utilized tool for staying on top of timely news stories and connecting with reporters 🎙️ #MyXAnniversary

Just became a fan of Best Buy and Geek Squad... but for its healthy-focused pilot program! Love the innovation - and positive outcome - of bringing Geek Squad services to chronic care patients ❤️ More on this from Heather Landi via FierceHealthcare

Been counting down the hours! Can't wait to hear from my amazing colleagues and reporter friendlies Mion Edwards and Anastassia Gliadkovskaya about the state of media in today's climate #FINNHealthSummit

Have a #crisis? Not communicating is not an option. It results in media filling in the blank... even if you don't have information, keep the flow of information coming. - John Bianchi & Claire Anderson via #FINNHealthSummit

Is your company prepared for a crisis? "Know your vulnerabilities and develop a plan with potential risks identified and scenarios that could take place" - John Bianchi via #FINNHealthSummit

I'm proud to be in Israel to honor the courage, commitment, and bravery of the Israeli people. Americans are grieving with you following last week’s terror attacks.

No suprises here! Congrats GrayMatters Health on this achievement 🏆 For the millions of people living with #PTSD, the innovation of GMH's Prism for PTSD offers new hope. An empowering treatment with impactful results. #Client

"I’m seeing it in conversations here with people. I hear it from colleagues in Europe and Japan. What we do matters, it always did, but #mentalhealth in general and #PTSD in particular, has not always gotten adequate attention. Now it does." - Oded Kraft, GrayMatters Health CEO and

Proud, and not in the least bit surprised 🏆 #FINNWin

Incredible to see the role #tech is playing in global #pandemic preparedness! Check out today's announcement from Picodya on its deployment of the first hybrid #IVD solution for multiplexed point-of-care testing to NIH labs. #client prnewswire.com/il/news-releas…

.... and a blood test for #Alzheimers is one step closer to becoming a reality! Check out ALZpath's latest publication in JAMA Neurology, affirming the high diagnostic accuracy of its ALZpath’s pTau217 blood test in identifying #amyloid and #tau in the brain. DM for info! #client

It was an absolute pleasure working with Alice Park at TIME on her latest piece featuring ALZpath Inc. and it's novel blood test for #Alzheimers. Give it a read! #ClientNews time.com/6565140/alzhei…

#Heartfailure impacts 6.9M Americans. Check out ن🇨🇵🍋Averoux's latest feature in FOX 9! Loved bringing this story to life! Learn about #Barostim, the world's first #neuromodulation device for #heartfailure management. fox9.com/news/medical-d…

#PTSD does not only impact #vets. 13 million Americans live with PTSD, stemming from physical assault, abuse, combat, illness, accidents or a natural disaster. Today, GrayMatters Health's novel Prism for PTSD is offering hope. Check out the peer-reviewed study! #selfneuromodulation

Oh, the power of the #PBM! "...while shifting to adalimumab biosimilars would save up to $6B for the US health system, PBMs would lose up to 84% of profit — a major reason very few large payers have come on board." - more from Zach Brennan via Endpoints News endpts.com/over-a-year-af…

Fantastic article by Jacob Bell via BioPharma Dive "For drug developers, the brain represents a final frontier of sorts, much like ocean’s depths or the reaches of space do for other scientists. Cracking it is “not for the faint of heart"..." biopharmadive.com/news/psychiatr…

Neurofeedback for #PTSD? It's not sci-fi. Data shows its clincial efficacy. Check out GrayMatters Health and the latest meta-analysis featuring Prism #neurofeedback!